| James Edward Butrynski, MD | |
|
520 Country Club Pkwy, Eugene, OR 97401-6043 | |
| (541) 683-5001 | |
| (541) 683-1422 |
| Full Name | James Edward Butrynski |
|---|---|
| Gender | Male |
| Speciality | Medical Oncology |
| Experience | 31 Years |
| Location | 520 Country Club Pkwy, Eugene, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427134287 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 230942 (Massachusetts) | Secondary |
| 207RH0003X | Internal Medicine - Hematology & Oncology | MD180586 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cascade Health Solutions | Eugene, OR | Hospice |
| Sacred Heart Medical Center - Riverbend | Springfield, OR | Hospital |
| Peace Harbor Medical Center | Florence, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oncology Associates Of Oregon P C | 7214924406 | 34 |
News Archive
The Canadian Medical Association is pleased to announce that Sagkeeng First Nation of Manitoba is supporting the Principles to Guide Health Care Transformation in Canada, now endorsed by 133 organizations across the country.
Oncology researchers studying gene mutations in the childhood cancer neuroblastoma are refining their diagnostic tools to predict which patients are more likely to respond to drugs called ALK inhibitors that target such mutations. Removing some of the guesswork in diagnosis and treatment, the researchers say, may lead to more successful outcomes for children with this often-deadly cancer.
Lung cancer is the leading cause of cancer death throughout the world. Standard treatment methods do not usually result in long-term recovery. In addition to the proliferation of the tumour cells, the growth of blood vessels controls tumors development. The blood vessel growth is controlled by several signalling molecules. Scientists from the Max Planck Institute for Heart and Lung Research in Bad Nauheim and Justus Liebig University Giessen have discovered a molecule that plays a key role in this process. They succeeded in reducing tumour growth in their experiments by blocking the phosphodiesterase PDE4.
Alcoholics Anonymous and other 12-step programs, while effective, are not the be-all and end-all in psychosocial treatments for alcohol dependence, according to new review of studies.
ChemGenex Pharmaceuticals has announced that the United States Food and Drug Administration (FDA) has granted Orphan Drug status for the company's most advanced drug, Ceflatonin, for the treatment of chronic myeloid leukemia (CML).
› Verified 5 days ago
| Entity Name | Oncology Associates Of Oregon P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013989854 PECOS PAC ID: 7214924406 Enrollment ID: O20040429000103 |
News Archive
The Canadian Medical Association is pleased to announce that Sagkeeng First Nation of Manitoba is supporting the Principles to Guide Health Care Transformation in Canada, now endorsed by 133 organizations across the country.
Oncology researchers studying gene mutations in the childhood cancer neuroblastoma are refining their diagnostic tools to predict which patients are more likely to respond to drugs called ALK inhibitors that target such mutations. Removing some of the guesswork in diagnosis and treatment, the researchers say, may lead to more successful outcomes for children with this often-deadly cancer.
Lung cancer is the leading cause of cancer death throughout the world. Standard treatment methods do not usually result in long-term recovery. In addition to the proliferation of the tumour cells, the growth of blood vessels controls tumors development. The blood vessel growth is controlled by several signalling molecules. Scientists from the Max Planck Institute for Heart and Lung Research in Bad Nauheim and Justus Liebig University Giessen have discovered a molecule that plays a key role in this process. They succeeded in reducing tumour growth in their experiments by blocking the phosphodiesterase PDE4.
Alcoholics Anonymous and other 12-step programs, while effective, are not the be-all and end-all in psychosocial treatments for alcohol dependence, according to new review of studies.
ChemGenex Pharmaceuticals has announced that the United States Food and Drug Administration (FDA) has granted Orphan Drug status for the company's most advanced drug, Ceflatonin, for the treatment of chronic myeloid leukemia (CML).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Edward Butrynski, MD 520 Country Club Pkwy, Eugene, OR 97401-6043 Ph: (541) 683-5001 | James Edward Butrynski, MD 520 Country Club Pkwy, Eugene, OR 97401-6043 Ph: (541) 683-5001 |
News Archive
The Canadian Medical Association is pleased to announce that Sagkeeng First Nation of Manitoba is supporting the Principles to Guide Health Care Transformation in Canada, now endorsed by 133 organizations across the country.
Oncology researchers studying gene mutations in the childhood cancer neuroblastoma are refining their diagnostic tools to predict which patients are more likely to respond to drugs called ALK inhibitors that target such mutations. Removing some of the guesswork in diagnosis and treatment, the researchers say, may lead to more successful outcomes for children with this often-deadly cancer.
Lung cancer is the leading cause of cancer death throughout the world. Standard treatment methods do not usually result in long-term recovery. In addition to the proliferation of the tumour cells, the growth of blood vessels controls tumors development. The blood vessel growth is controlled by several signalling molecules. Scientists from the Max Planck Institute for Heart and Lung Research in Bad Nauheim and Justus Liebig University Giessen have discovered a molecule that plays a key role in this process. They succeeded in reducing tumour growth in their experiments by blocking the phosphodiesterase PDE4.
Alcoholics Anonymous and other 12-step programs, while effective, are not the be-all and end-all in psychosocial treatments for alcohol dependence, according to new review of studies.
ChemGenex Pharmaceuticals has announced that the United States Food and Drug Administration (FDA) has granted Orphan Drug status for the company's most advanced drug, Ceflatonin, for the treatment of chronic myeloid leukemia (CML).
› Verified 5 days ago
Richard Romm, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 677 E 12th Ave, Suite N400, Eugene, OR 97401 Phone: 541-484-4332 Fax: 541-302-0786 | |
William E Wilkins Jr., M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 330 S Garden Way Ste 350, Eugene, OR 97401 Phone: 541-746-6816 | |
Dr. Norman Paul Hudson, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 2479 Oakmont Way, Eugene, OR 97401 Phone: 541-484-0195 Fax: 541-343-6317 | |
Kirk Douglas Jacobson, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1488 Oak St, Eugene, OR 97401 Phone: 541-431-0000 Fax: 541-344-6176 | |
Matthew B. Walter, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3125 Chad Dr Ste 100, Eugene, OR 97408 Phone: 541-687-1712 Fax: 541-687-7943 | |
Sarah Cassell, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 132 E Broadway Ste 830, Eugene, OR 97401 Phone: 541-687-0816 Fax: 541-687-1086 | |
Dr. Klarissa N Beller, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1200 Hilyard St Ste 520a, Eugene, OR 97401 Phone: 541-687-6041 Fax: 541-687-6009 |